Search Results - "Simon, Teresa A."

Safety of abatacept compared with other biologic and conventional synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: data from an observational study by Ozen, Gulsen, Pedro, Sofia, Schumacher, Rebecca, Simon, Teresa A, Michaud, Kaleb

“…To assess the risks of malignancies, infections and autoimmune diseases in patients with rheumatoid arthritis (RA) treated with abatacept compared with other…”
Get full text

High-quality cooperative research: studies that represent a triumph in the rheumatology community by Simon, Teresa A

“…Over the past 20 years, the rheumatoid arthritis (RA) treatment landscape has been continuously evolving. A range of novel biologic agents, different from the…”
Get full text

Abatacept initiation in rheumatoid arthritis and the risk of cancer: a population-based comparative cohort study by Montastruc, François, Renoux, Christel, Dell'Aniello, Sophie, Simon, Teresa A, Azoulay, Laurent, Hudson, Marie, Suissa, Samy

“…Abstract Objective To assess whether abatacept as initial biological DMARD (bDMARD) in the treatment of RA, when compared with other bDMARDs, is associated…”
Get full text

Experiences of Patients With Rheumatic Diseases in the United States During Early Days of the COVID‐19 Pandemic by Michaud, Kaleb, Wipfler, Kristin, Shaw, Yomei, Simon, Teresa A., Cornish, Adam, England, Bryant R., Ogdie, Alexis, Katz, Patricia

“…Objective Patients with rheumatic diseases such as rheumatoid arthritis (RA) and lupus have increased risk of infection and are treated with medications that…”
Get full text

Comparative risk of malignancies and infections in patients with rheumatoid arthritis initiating abatacept versus other biologics: a multi-database real-world study by Simon, Teresa A, Boers, Maarten, Hochberg, Marc, Baker, Nicole, Skovron, Mary L, Ray, Nitesh, Singhal, Sanket, Suissa, Samy, Gomez-Caminero, Andres

“…Patients with rheumatoid arthritis (RA) are at an increased risk of developing certain cancers and infections compared with the general population. Biologic…”
Get full text

Risk of opportunistic infections in patients with rheumatoid arthritis initiating abatacept: cumulative clinical trial data by Simon, Teresa A, Dong, Lixian, Winthrop, Kevin L

“…To evaluate incidence of opportunistic infections (OIs) in patients with rheumatoid arthritis (RA) treated with abatacept in clinical trials. This pooled…”
Get full text

Pregnancy outcomes following exposure to abatacept during pregnancy by Kumar, Monica, MD, MPH, Ray, Laura, RN, Vemuri, Sudha, PhD, Simon, Teresa A., MPH

“…Abstract Objective To characterize pregnancy outcomes following maternal and paternal exposure to abatacept, using clinical trial and post-marketing data…”
Get full text

Abatacept initiation in rheumatoid arthritis and the risk of serious infection: A population-based cohort study by Montastruc, François, Renoux, Christel, Hudson, Marie, Dell'Aniello, Sophie, Simon, Teresa A., Suissa, Samy

“…To assess whether abatacept as initial biologic disease-modifying antirheumatic drug (DMARD) in the treatment of rheumatoid arthritis is associated with an…”
Get full text

The risk of hospitalized infection in patients with rheumatoid arthritis by SMITTEN, Allison L, CHOI, Hyon K, HOCHBERG, Marc C, SUISSA, Samy, SIMON, Teresa A, TESTA, Marcia A, CHAN, K. Arnold

“…OBJECTIVE: To determine whether patients with rheumatoid arthritis (RA) are at increased risk of hospitalized infection and whether the risk varies by RA…”
Get full text

Safety outcomes in patients with rheumatoid arthritis treated with abatacept: results from a multinational surveillance study across seven European registries by Dominique, Alyssa, Hetland, Merete Lund, Finckh, Axel, Gottenberg, Jacques-Eric, Iannone, Florenzo, Caporali, Roberto, Kou, Tzuyung Douglas, Nordstrom, Dan, Hernandez, Maria Victoria, Sánchez-Piedra, Carlos, Sánchez-Alonso, Fernando, Pavelka, Karel, Bond, T Christopher, Simon, Teresa A

“…Patients with rheumatoid arthritis (RA) have an increased risk of infection and malignancy compared with the general population. Infection risk is increased…”
Get full text

Prevalence of co-existing autoimmune disease in juvenile idiopathic arthritis: a cross-sectional study by Simon, Teresa A, Harikrishnan, Gowri Priya, Kawabata, Hugh, Singhal, Sanket, Brunner, Hermine I, Lovell, Daniel J

“…Many autoimmune diseases share common pathogenic mechanisms, cytokine pathways and systemic inflammatory cascades; however, large studies quantifying the…”
Get full text

Quality of life, activity impairment, and healthcare resource utilization associated with atrial fibrillation in the US National Health and Wellness Survey by Goren, Amir, Liu, Xianchen, Gupta, Shaloo, Simon, Teresa A, Phatak, Hemant

“…This study builds upon current studies of atrial fibrillation (AF) and health outcomes by examining more comprehensively the humanistic burden of illness…”
Get full text

Rates of first infection following kidney transplant in the United States by Snyder, Jon J., Israni, Ajay K., Peng, Yi, Zhang, Lin, Simon, Teresa A., Kasiske, Bertram L.

“…We studied the incidence, trends and clinical correlates of infections following kidney transplantation in the United States Renal Data System over the years…”
Get full text

Prevalence of autoimmune diseases and other associated conditions in children and young adults with juvenile idiopathic arthritis by Lovell, Daniel J, Huang, Bin, Chen, Chen, Angeles-Han, Sheila T, Simon, Teresa A, Brunner, Hermine I

“…ObjectiveMany autoimmune diseases share common pathogenic mechanisms; however, there are limited studies quantifying the coexistence of autoimmune diseases and…”
Get full text

Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis by Simon, Teresa A, Thompson, Adam, Gandhi, Kunal K, Hochberg, Marc C, Suissa, Samy

“…Patients with rheumatoid arthritis (RA) are at an increased risk of malignancies compared with the general population. This has raised concerns regarding these…”
Get full text

Infections requiring hospitalization in the abatacept clinical development program: an epidemiological assessment by Simon, Teresa A, Askling, Johan, Lacaille, Diane, Franklin, Jarrod, Wolfe, Frederick, Covucci, Allison, Suissa, Samy, Hochberg, Marc C

“…Patients with rheumatoid arthritis (RA) have an increased risk of infection and this risk appears to be higher with anti-TNF (tumor necrosis factor) agents. We…”
Get full text

Increase in Cannabis Use Among Adults With Rheumatic Diseases: Results From a 2014–2019 United States Observational Study by Wipfler, Kristin, Simon, Teresa A., Katz, Patricia, Wolfe, Frederick, Michaud, Kaleb

“…Objective Despite advances in treatments and outcomes among patients with rheumatic diseases, there is an unmet need in pain management. Cannabis has emerged…”
Get full text

Initiation of warfarin in patients with atrial fibrillation: early effects on ischaemic strokes by Azoulay, Laurent, Dell'Aniello, Sophie, Simon, Teresa A, Renoux, Christel, Suissa, Samy

“…An increased risk of stroke was observed in two atrial fibrillation (AF) trials of oral factor Xa inhibitors, when patients were transitioned to open label…”
Get full text

Development of Resilience Among Rheumatoid Arthritis Patients: A Qualitative Study by Shaw, Yomei, Bradley, Matthew, Zhang, Chen, Dominique, Alyssa, Michaud, Kaleb, McDonald, David, Simon, Teresa A.

“…Objective Resilience, the ability to recover from and adapt successfully to stressful situations, is a valuable resource for patients who live with chronic…”
Get full text

Comparative effectiveness of treatments for rheumatoid arthritis in clinical practice: A systematic review by Sparks, Jeffrey A., Harrold, Leslie R., Simon, Teresa A., Wittstock, Keith, Kelly, Sheila, Lozenski, Karissa, Khaychuk, Vadim, Michaud, Kaleb

“…•Systematic review of b/tsDMARDs in adults with RA•Outcomes data were extracted from 67 real-world comparative effectiveness studies•There were no evident…”
Get full text